Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

Verified by: National Institute on Drug Abuse (NIDA), April 2010
First Received: February 19, 2004 | Last Updated: April 13, 2010 | Phase: Phase 3 | Start Date: October 2003
Overall Status: Completed | Estimated Enrollment: 200
  • …
  • Tell a FriendPrint

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women...

Brief Summary

Official Title: “Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users”

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

  • Study Type: Interventional
  • Study Design: Primary Purpose: Treatment
  • Study Primary Completion Date: April 2006

Intervention(s) in this Clinical Trial

  • Behavioral: Behavior Therapy

Outcome Measures for this Clinical Trial

Primary Measures

  • Treatment Utilization
  • Substance Abuse

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Pregnancy <30 weeks
  • Have not attended drug treatment in past 28 days
  • Not needing residential treatment (except detox)
  • Not at risk for suicide/homicide
  • Have no pending legal charges (except drug treatment)

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: University of Cincinnati Other

Overall Clinical Trial Officials and Contacts

Theresa Winhusen, Ph.D. Principal Investigator University of Cincinnati  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00078143

Study ID Number: NIDA-CTN-0013-1

ClinicalTrials.gov Identifier: NCT00078143

Health Authority: United States: Federal Government

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00078143